6.770USD+0.30%Mkt Cap: 49.50M $P/E: —1d ago
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data anal…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap49.50M $
Enterprise Value61.16M $
Revenue (TTM)21.19M $
Gross Profit12.66M $
Net Income (TTM)-41.71M $
Revenue/Share4.208 USD
Last Price6.770 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees160
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.96
PEG—
EV/EBITDA-1.90
EV/Revenue2.89
P/S2.34
P/B0.79
EPS (TTM)-8.50
EPS (Forward)-0.68
52W Range
5.8458% of range17.74
52W High17.74 USD
52W Low5.845 USD
Profitability
Gross Margin56.64%
Oper. Margin-130.89%
EBITDA Margin-151.71%
Profit Margin-186.56%
ROE-61.41%
ROA-37.90%
Growth
Revenue Growth-17.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.94M $
CapEx (TTM)142.00K $
FCF Margin-51.34%
FCF Yield-21.98%
Net Debt11.80M $
Net Debt/EBITDA-0.37
Balance Sheet
Debt/Equity0.47
Current Ratio3.07
Quick Ratio2.57
Book Value/Sh8.546 USD
Cash/Share2.737 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateNov 18, 2019
Splits
Last Split1:20
Split DateAug 28, 2025
Analyst Consensus
Rating—
Target (Mean)18.50 USD
Upside (mean)+173.3%
Target Range10.00 USD – 28.00 USD
$10.00+173.3% to mean$28.00
# Analysts4
Ownership
Shares Out.7.31M
Float5.23M
Insiders21.08%
Institutions12.03%
Short Interest
Short Ratio7.4d
Short % Float1.08%
Short % Out.1.05%
Shares Short76.97K
Short (prev mo.)70.66K
Technical
SMA 507.377 (-8.2%)
SMA 20010.29 (-34.2%)
Beta1.09
S&P 52W Chg20.25%
Avg Vol (30d)12.21K
Avg Vol (10d)16.00K
Technical Indicators
RSI (14)46.3
MACD-0.1331
MACD Signal-0.1588
MACD Hist.+0.0257
BB Upper7.550 USD
BB Middle6.770 USD
BB Lower5.990 USD
BB Width23.05%
ATR (14)0.5062 USD
Vol Ratio (20d)0.44x